TMCnet News
Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx ConferenceCAMBRIDGE, Mass., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, chief executive officer, and Vito Palombella, Ph.D., chief scientific officer, will participate in a fireside chat at the Evercore ISI 2nd Annual HealthCONx Conference. The presentation will take place on Wednesday, December 4th, 2019 at 8:20 a.m. ET at the Four Seasons Hotel in Boston, Mass. The live audio and subsequent archived webcasts of the Company's presentations will be accessible from the Compny's investor relations website, investors.surfaceoncology.com. About Surface Oncology: Contacts: Media |